PIQUR is a Swiss pharmaceutical company focusing on innovative anti-cancer drugs based on PI3K and mTOR inhibition. In January 2014 PIQUR launched the clinical Phase I study with the active ingredient PQR309.

Company Name:

PIQUR Therapeutics AG

Trading Symbol(s):

[]

Contact:

Tatsuo Satoh - Piqur.com

Address:

Confidential

City:

Basel

Zip code:

CH-4058

STATE / Prov.:

Schweiz

Country:

Switzerland

Primary Industry:

Pharma/BioTech/Nutrition

PR Agency:

No

Your Company Advertising Here!Showing along with this industry- Learn more...